AI Science Tracker
EN

Metabolic pathway activation and immune microenvironment features in non-small cell lung cancer: insights from single-cell transcriptomics.

West China Second University Hospital; Sichuan University; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University); s Central Hospital; School of Medicine; University of Electronic Science and Technology of China · 28 Feb 2025 · medicine

Discovery

Metabolic pathway activation and immune microenvironment features in non-small cell lung cancer: insights from single-cell transcriptomics.

Source check: Source checked. Not independent scientific confirmation.

Finding: Specific metabolic and immune findings are linked to learned prioritization; cell assays support KRT6B function, while clinical application remains unproven. Single-cell RNA-seq defines cell groups and pathway states; learned risk score is evaluated across cohorts and KRT6B is tested in wet-lab assays. Testing: Primary Results describe the specific comparator, cohort or experimental check; limitations are stated narrowly.. Single-cell pathway analysis and machine-learning risk signatures linked NSCLC metabolic states to KRT6B, whose expression and proliferation role were experimentally tested. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.

Technology: Single-cell RNA-seq defines cell groups and pathway states; learned risk score is evaluated across cohorts and KRT6B is tested in wet-lab assays.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Single-cell RNA-seq defines cell groups and pathway states; learned risk score is evaluated across cohorts and KRT6B is tested in wet-lab assays.
Test and result
Primary Results describe the specific comparator, cohort or experimental check; limitations are stated narrowly.
Limitation / still unknown
Generalizability beyond the reported study population, data, and protocol was not established in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1546764/full · https://europepmc.org/article/MED/40092988

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.